Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma

Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma

In diffuse large B-cell lymphoma (DLBCL) treatment response relies on imaging. We investigated the potential value of molecular measurable residual disease (MRD) on circulating tumor DNA (ctDNA) to predict patient outcomes. We retrospectively evaluated 73 patients. Analyses were conducted on 57 t...

Full description

Saved in:
Bibliographic Details
Main Authors: Roberta Soscia, Giovanni Manfredi Assanto, Irene Della Starza, Riccardo Moia, Donatella Talotta, Vittorio Bellomarino, Teresa Bellissimo, Marco Antonacci, Luigi Petrucci, Gianluca Gaidano, Anna Guarini, Maurizio Martelli, Alice Di Rocco, Robin Foà, Ilaria Del Giudice
Format: Article
Language:English
Published: Ferrata Storti Foundation 2024-12-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/11878
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://haematologica.org/article/view/11878

Similar Items